CN Stock MarketDetailed Quotes

Sichuan Kelun Pharmaceutical (002422)

Watchlist
  • 40.02
  • -0.50-1.23%
15min DelayMarket Closed Sep 17 15:00 CST
63.66BMarket Cap34.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Kelun Pharmaceutical (002422) Revenue Breakdown Overview

By Product

Currency:CNY
2026/H1
Stock NameRevenueRatio
Non infusion4.65B52.56%
Infusion3.56B40.27%
Research and development projects320.91M3.63%
Other business312.7M3.54%

By Industry

Currency:CNY
2026/H1
Stock NameRevenueRatio
Pharmaceutical manufacturing8.2B92.83%
Research and development projects320.91M3.63%
Other312.7M3.54%

By Country/Region

Currency:CNY
2026/H1
Stock NameRevenueRatio
East China2.52B28.55%
Southwest1.69B19.09%
Central China1.1B12.41%
North China1.03B11.61%
International business770.54M8.72%
South China769.34M8.70%
Northwest348.83M3.95%
Other business312.7M3.54%
Northeast China303.31M3.43%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.